Guideline | Drug Name |
---|---|
Xolair (omalizumab) | Xolair (omalizumab) |
Xolremdi (mavorixafor) | Xolremdi (mavorixafor) |
Xospata (gilteritinib) | Xospata (gilteritinib) tablets |
Xphozah (tenapanor) - ST, NF | Xphozah (tenapanor) |
Xpovio (selinexor) | Xpovio (selinexor) |
Xromi (hydroxyurea) | Xromi (hydroxyurea) |
Xtandi (enzalutamide) | Xtandi (enzalutamide) |
Xuriden (uridine triacetate) | Xuriden (uridine triacetate) |
Yonsa (abiraterone acetate) - PA, NF | Yonsa (abiraterone acetate) |
Yorvipath (palopegteriparatide) | Yorvipath (palopegteriparatide) |
Zejula (niraparib) | Zejula (niraparib) |
Zelboraf (vemurafenib) | Zelboraf (vemurafenib) |
Zepatier (elbasvir/grazoprevir) | Zepatier (elbasvir/grazoprevir) |
Zeposia (ozanimod) | Zeposia (ozanimod) |
Zevaskyn (prademagene zamikeracel) | Zevaskyn (prademagene zamikeracel) |
Ziihera (zanidatamab-hrii) | Ziihera (zanidatamab-hrii) injection |
Zilbrysq (zilucoplan injection) | Zilbrysq (zilucoplan injection) |
Zokinvy (lonafarnib) | Zokinvy (lonafarnib) |
Zolgensma (onasemnogene abeparvovec-xioi) - PA, NF | Zolgensma (onasemnogene abeparvovec-xioi) |
Zolinza (vorinostat) | Zolinza (vorinostat) |